154 related articles for article (PubMed ID: 34164801)
1. Heterozygous HMGB1 loss-of-function variants are associated with developmental delay and microcephaly.
Uguen K; Krysiak K; Audebert-Bellanger S; Redon S; Benech C; Viora-Dupont E; Tran Mau-Them F; Rondeau S; Elsharkawi I; Granadillo JL; Neidich J; Soares CA; Tkachenko N; M Amudhavalli S; Engleman K; Boland A; Deleuze JF; Bezieau S; Odent S; Toutain A; Bonneau D; Gilbert-Dussardier B; Faivre L; Rio M; Le Marechal C; Ferec C; Repnikova E; Cao Y
Clin Genet; 2021 Oct; 100(4):386-395. PubMed ID: 34164801
[TBL] [Abstract][Full Text] [Related]
2. A newly recognized 13q12.3 microdeletion syndrome characterized by intellectual disability, microcephaly, and eczema/atopic dermatitis encompassing the HMGB1 and KATNAL1 genes.
Bartholdi D; Stray-Pedersen A; Azzarello-Burri S; Kibaek M; Kirchhoff M; Oneda B; Rødningen O; Schmitt-Mechelke T; Rauch A; Kjaergaard S
Am J Med Genet A; 2014 May; 164A(5):1277-83. PubMed ID: 24664804
[TBL] [Abstract][Full Text] [Related]
3. Isolated chromosome 8p23.2‑pter deletion: Novel evidence for developmental delay, intellectual disability, microcephaly and neurobehavioral disorders.
Shi S; Lin S; Chen B; Zhou Y
Mol Med Rep; 2017 Nov; 16(5):6837-6845. PubMed ID: 28901431
[TBL] [Abstract][Full Text] [Related]
4. CNV analysis using whole exome sequencing identified biallelic CNVs of VPS13B in siblings with intellectual disability.
Enomoto Y; Tsurusaki Y; Yokoi T; Abe-Hatano C; Ida K; Naruto T; Mitsui J; Tsuji S; Morishita S; Kurosawa K
Eur J Med Genet; 2020 Jan; 63(1):103610. PubMed ID: 30602132
[TBL] [Abstract][Full Text] [Related]
5. Whole exome sequencing identifies a novel 5 Mb deletion at 14q12 region in a patient with global developmental delay, microcephaly and seizures.
Vineeth VS; Dutta UR; Tallapaka K; Das Bhowmik A; Dalal A
Gene; 2018 Oct; 673():56-60. PubMed ID: 29920362
[TBL] [Abstract][Full Text] [Related]
6. A novel phenotype of 13q12.3 microdeletion characterized by epilepsy in an Asian child: a case report.
Wang M; Li B; Liao Z; Jia Y; Fu Y
BMC Med Genomics; 2020 Oct; 13(1):144. PubMed ID: 33023587
[TBL] [Abstract][Full Text] [Related]
7. De novo missense variants in MEIS2 recapitulate the microdeletion phenotype of cardiac and palate abnormalities, developmental delay, intellectual disability and dysmorphic features.
Douglas G; Cho MT; Telegrafi A; Winter S; Carmichael J; Zackai EH; Deardorff MA; Harr M; Williams L; Psychogios A; Erwin AL; Grebe T; Retterer K; Juusola J
Am J Med Genet A; 2018 Sep; 176(9):1845-1851. PubMed ID: 30055086
[TBL] [Abstract][Full Text] [Related]
8. Developmental delay and failure to thrive associated with a loss-of-function variant in WHSC1 (NSD2).
Boczek NJ; Lahner CA; Nguyen TM; Ferber MJ; Hasadsri L; Thorland EC; Niu Z; Gavrilova RH
Am J Med Genet A; 2018 Dec; 176(12):2798-2802. PubMed ID: 30345613
[TBL] [Abstract][Full Text] [Related]
9. Rare GABRA3 variants are associated with epileptic seizures, encephalopathy and dysmorphic features.
Niturad CE; Lev D; Kalscheuer VM; Charzewska A; Schubert J; Lerman-Sagie T; Kroes HY; Oegema R; Traverso M; Specchio N; Lassota M; Chelly J; Bennett-Back O; Carmi N; Koffler-Brill T; Iacomino M; Trivisano M; Capovilla G; Striano P; Nawara M; Rzonca S; Fischer U; Bienek M; Jensen C; Hu H; Thiele H; Altmüller J; Krause R; May P; Becker F; ; Balling R; Biskup S; Haas SA; Nürnberg P; van Gassen KLI; Lerche H; Zara F; Maljevic S; Leshinsky-Silver E
Brain; 2017 Nov; 140(11):2879-2894. PubMed ID: 29053855
[TBL] [Abstract][Full Text] [Related]
10. Deletion of
Singh R; Cohen ASA; Poulton C; Hjortshøj TD; Akahira-Azuma M; Mendiratta G; Khan WA; Azmanov DN; Woodward KJ; Kirchhoff M; Shi L; Edelmann L; Baynam G; Scott SA; Jabs EW
Cold Spring Harb Mol Case Stud; 2021 Jun; 7(3):. PubMed ID: 34117072
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic expansion of the BPTF-related neurodevelopmental disorder with dysmorphic facies and distal limb anomalies.
Glinton KE; Hurst ACE; Bowling KM; Cristian I; Haynes D; Adstamongkonkul D; Schnappauf O; Beck DB; Brewer C; Parikh AS; Shinde DN; Donaldson A; Brautbar A; Koene S; van Haeringen A; Piton A; Capri Y; Furlan M; Gardella E; Møller RS; van de Beek I; Zuurbier L; Lakeman P; Bayat A; Martinez J; Signer R; Torring PM; Engelund MB; Gripp KW; Amlie-Wolf L; Henderson LB; Midro AT; Tarasów E; Stasiewicz-Jarocka B; Moskal-Jasinska D; Vos P; Boschann F; Stoltenburg C; Puk O; Mero IL; Lossius K; Mignot C; Keren B; Acosta Guio JC; Briceño I; Gomez A; Yang Y; Stankiewicz P
Am J Med Genet A; 2021 May; 185(5):1366-1378. PubMed ID: 33522091
[TBL] [Abstract][Full Text] [Related]
12. Complex craniosynostosis is associated with the 2p15p16.1 microdeletion syndrome.
Florisson JM; Mathijssen IM; Dumee B; Hoogeboom JA; Poddighe PJ; Oostra BA; Frijns JP; Koster L; de Klein A; Eussen B; de Vries BB; Swagemakers S; van der Spek PJ; Verkerk AJ
Am J Med Genet A; 2013 Feb; 161A(2):244-53. PubMed ID: 23303641
[TBL] [Abstract][Full Text] [Related]
13. Homozygous loss-of-function variants of TASP1, a gene encoding an activator of the histone methyltransferases KMT2A and KMT2D, cause a syndrome of developmental delay, happy demeanor, distinctive facial features, and congenital anomalies.
Suleiman J; Riedhammer KM; Jicinsky T; Mundt M; Werner L; Gusic M; Burgemeister AL; Alsaif HS; Abdulrahim M; Moghrabi NN; Nicolas-Jilwan M; AlSayed M; Bi W; Sampath S; Alkuraya FS; El-Hattab AW
Hum Mutat; 2019 Nov; 40(11):1985-1992. PubMed ID: 31209944
[TBL] [Abstract][Full Text] [Related]
14. WAC loss-of-function mutations cause a recognisable syndrome characterised by dysmorphic features, developmental delay and hypotonia and recapitulate 10p11.23 microdeletion syndrome.
DeSanto C; D'Aco K; Araujo GC; Shannon N; ; Vernon H; Rahrig A; Monaghan KG; Niu Z; Vitazka P; Dodd J; Tang S; Manwaring L; Martir-Negron A; Schnur RE; Juusola J; Schroeder A; Pan V; Helbig KL; Friedman B; Shinawi M
J Med Genet; 2015 Nov; 52(11):754-61. PubMed ID: 26264232
[TBL] [Abstract][Full Text] [Related]
15. Loss-of-function variants in NFIA provide further support that NFIA is a critical gene in 1p32-p31 deletion syndrome: A four patient series.
Revah-Politi A; Ganapathi M; Bier L; Cho MT; Goldstein DB; Hemati P; Iglesias A; Juusola J; Pappas J; Petrovski S; Wilson AL; Aggarwal VS; Anyane-Yeboa K
Am J Med Genet A; 2017 Dec; 173(12):3158-3164. PubMed ID: 28941020
[TBL] [Abstract][Full Text] [Related]
16. IGF1R Variants in Patients With Growth Impairment: Four Novel Variants and Genotype-Phenotype Correlations.
Yang L; Xu DD; Sun CJ; Wu J; Wei HY; Liu Y; Zhang MY; Luo FH
J Clin Endocrinol Metab; 2018 Nov; 103(11):3939-3944. PubMed ID: 30053089
[TBL] [Abstract][Full Text] [Related]
17. Clinical characterization of individuals with the distal 1q21.1 microdeletion.
Edwards SD; Schulze KV; Rosenfeld JA; Westerfield LE; Gerard A; Yuan B; Grigorenko EL; Posey JE; Bi W; Liu P
Am J Med Genet A; 2021 May; 185(5):1388-1398. PubMed ID: 33576134
[TBL] [Abstract][Full Text] [Related]
18. Elucidation of the phenotypic spectrum and genetic landscape in primary and secondary microcephaly.
Boonsawat P; Joset P; Steindl K; Oneda B; Gogoll L; Azzarello-Burri S; Sheth F; Datar C; Verma IC; Puri RD; Zollino M; Bachmann-Gagescu R; Niedrist D; Papik M; Figueiro-Silva J; Masood R; Zweier M; Kraemer D; Lincoln S; Rodan L; ; Passemard S; Drunat S; Verloes A; Horn AHC; Sticht H; Steinfeld R; Plecko B; Latal B; Jenni O; Asadollahi R; Rauch A
Genet Med; 2019 Sep; 21(9):2043-2058. PubMed ID: 30842647
[TBL] [Abstract][Full Text] [Related]
19. Novel compound heterozygous mutations in GPT2 linked to microcephaly, and intellectual developmental disability with or without spastic paraplegia.
Kaymakcalan H; Yarman Y; Goc N; Toy F; Meral C; Ercan-Sencicek AG; Gunel M
Am J Med Genet A; 2018 Feb; 176(2):421-425. PubMed ID: 29226631
[TBL] [Abstract][Full Text] [Related]
20. Haploinsufficiency of AKT3 gene causing microcephaly and psychomotor delay in a patient with 1q43q44 microdeletion.
Pelle A; Modena P; Cavallini A; Selicorni A
Clin Dysmorphol; 2020 Apr; 29(2):97-100. PubMed ID: 31929334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
